R&D Advantage

Research Team

Mr. Danny Wong, the chairman of Medisun, has brought together a group of top scientists, experts and advisors in the field of stem cell research and therapy from Europe, US and Japan to form an international research and development team. The team collectively brings in extensive knowledge, skills and experience in stem cell therapies and is well equipped to develop and deliver the most advanced stem cell-based products to patients with various diseases around the world.

Industrial Base

Medisun has finished constructing a 10,000 square feet stem cell GMP production facility in Hong Kong alongside a 10,000 square feet medical center with state-of-the-art equipment. These facilities will be used to support C-Cure®’s Phase III clinical trial in Hong Kong and Mainland China as well as to provide diagnosis and approved treatments for patients from across Asia.